A propensity score matching study on clinical characteristics and risk factors of herpes zoster in malignant tumor - Takeaways - MDSpire

A propensity score matching study on clinical characteristics and risk factors of herpes zoster in malignant tumor

  • By

  • Yang Li

  • Canhua Liang

  • Ziwei Feng

  • Shaohuan Lu

  • GuangZhao Wang

  • Guangyi Meng

  • May 13, 2026

  • 0 min

Share

  • 1

    Herpes zoster (HZ) is more prevalent in cancer patients due to immune suppression from the disease and its treatments.

  • 2

    The study analyzed data from cancer patients diagnosed between January 2020 and September 2024 to assess HZ risk factors.

  • 3

    Hematologic cancers, particularly multiple myeloma, significantly increase the risk of developing HZ compared to solid tumors.

  • 4

    89.89% of HZ cases occurred within 12 months after the initiation of anticancer therapy, indicating a strong temporal association.

  • 5

    The use of immune checkpoint inhibitors did not significantly elevate the risk of HZ in cancer patients.

Original Source(s)

A propensity score matching study on clinical characteristics and risk factors of herpes zoster in malignant tumor

  • by Yang Li, Canhua Liang, Ziwei Feng, Shaohuan Lu, GuangZhao Wang, Guangyi Meng

  • May 13, 2026

Related Content

FOXA2 in cancer: from fundamental biology to clinical translation

Is full adherence mandatory? Real-world outcomes of completing perioperative chemoimmunotherapy in resectable non-small cell lung cancer

MRI perfusion in evaluating ovarian masses: diagnostic performance of wash out rate